Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ drug supplies as a potential first step to imposing restrictions. | A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ drug supplies, marking a potential first step to imposing restrictions.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Lawmakers want more transparency around foreign influence in the sector, saying there’s no reason to allow rival to control…

Two federal lawmakers have introduced a bill seeking to apply the review requi | Two federal lawmakers have introduced a bill…

Amid multiple efforts to rein in steep drug costs in the U.S., Colorado has received the all-clear to take matters into its own…

As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to block…

Amid efforts in Germany to retool the country’s drug spending, the U.S. | Amid efforts in Germany to retool the country’s drug…

A bipartisan group of lawmakers in both chambers of Congress has reintroduced a bill aimed at barring companies from owning both…